Field evaluation of a visual barrier to discourage gull nesting

Expanding gull populations along the Columbia River have been implicated in depredations to threatened and endangered migrating salmon smolt, depredations to agriculture crops, bird-aircraft strike hazards, nuisance problems, and potential threats to public health. In an effort to develop management methods for controlling gull populations, we tested a visual barrier to discourage gulls from nesting on an island in the Columbia River. The barrier material is a woven black polypropylene fabric that we utilized to take advantage of the gulls\u27 innate predator avoidance mechanisms, by removing their line of sight to approaching terrestrial predators while providing no protection from aerial predators. The visual barrier was installed on Upper Nelson Island, Benton County, Washington, in a 70 x 70 m area composed of parallel rows spaced 5 m apart. Gulls used 87% of the 7.9 ha island as nesting habitat and we estimated \u3e21,000 gull nests, 80% Ring-billed Gull and 20% California Gull nests. However, Ring-billed Gulls occupied only 38% of the nesting territory, while California Gulls occupied the remainder. The treated and control zones occupied about 12.3% of the gull nesting habitat on the island. The area with fencing had 84% fewer nests than the control area. Silt fencing has potential as a nonlethal bird management technique in certain situations and should be further evaluated as a nesting deterrent

Field Evaluation of a Visual Barrier to Discourage Gull Nesting

Expanding gull populations along the Columbia River have been implicated in depredations to threatened and endangered migrating salmon smolt, depredations to agriculture crops, bird-aircraft strike hazards, nuisance problems, and potential threats to public health. In an effort to develop management methods for controlling gull populations, we tested a visual barrier to discourage gulls from nesting on an island in the Columbia River. The barrier material is a woven black polypropylene fabric that we utilized to take advantage of the gulls\u27 innate predator avoidance mechanisms, by removing their line of sight to approaching terrestrial predators while providing no protection from aerial predators. The visual barrier was installed on Upper Nelson Island, Benton County, Washington, in a 70 x 70 m area composed of parallel rows spaced 5 m apart. Gulls used 87% of the 7.9 ha island as nesting habitat and we estimated \u3e21,000 gull nests, 80% Ring-billed Gull and 20% California Gull nests. However, Ring-billed Gulls occupied only 38% of the nesting territory, while California Gulls occupied the remainder. The treated and control zones occupied about 12.3% of the gull nesting habitat on the island. The area with fencing had 84% fewer nests than the control area. Silt fencing has potential as a nonlethal bird management technique in certain situations and should be further evaluated as a nesting deterrent

Translocating Common Nighthawks at McConnell Air Force Base, Kansas to Reduce Aircraft Strikes

McConnell Air Force Base (MAFB) experiences a unique bird/aircraft hazard problem with migrating common nighthawks (Chordeiles minor) from August-October. Nighthawks are the most commonly struck species at MAFB, representing about 38% of total reported bird/aircraft strikes and 82% of the strikes from August-October. Factors that contribute to an over abundance of nighthawks on MAFB are: abundant foraging opportunities in close proximity to the airfield, available roosting habitat for nighthawks on and around the airfield, the lack of a Bird Aircraft Strike Hazard program to address nighthawks, and the location of MAFB on a nighthawk migration route. Approaches for managing nighthawks on and around airfields are limited because of their nocturnal behavior, logistics, and an incomplete understanding of nighthawk behavior. At MAFB, we determined the number of nighthawks using the airfield; their foraging, loafing and roosting areas; and their feeding habits. Based on this information, we developed a management strategy to reduce the nighthawk hazard to aircraft. From August-October in 1999 and 2000, we recorded 540 and 920 observations, respectively, of nighthawks using the airfield. The number of individuals increased rapidly during August and September, reaching a peak between 9-14 September in 1999 and 27-30 September in 2000. During one 2-hour survey period each in 1999 and 2000, 37 and 59 nighthawks, respectively, were flushed from the airfield. Most nighthawk foraging activity at the airfield occurred between 1800-2200. Nighthawks started roosting on the airfield about 1800 with a peak between 2200-0200. Thirty-seven nighthawks collected during the study period consumed a variety of insects, consisting mostly of corn earworm moths (Noctuidae—47% of stomach contents) and beetles (Scarabaeidae). Insect sweeps of the airfield indicated a low density of these species of insects, suggesting that most nighthawks foraging activity occurred away from the airfield. Management of nighthawks on MAFB has been difficult because commonly used hazing techniques seem to be ineffective. Furthermore, nighthawks have a behavior of returning to the same roosting location after being flushed which can present an even greater risk to aircraft. We developed and evaluated a unique live-capture technique for nighthawks using the airfield for the purpose of evaluating nighthawk relocation. During 1999 and 2000, 215 nighthawks were captured and relocated to sites 44 km north and 88 km south from MAFB. Only one nighthawk returned to MAFB after being relocated 44 km north. The nighthawk returned after 11 days to within 100 m of its capture location. Relocation of nighthawks from MAFB in 1999 and 2000 reduced nighthawk/aircraft strikes from 9 in 1998 when no relocation was conducted to 0 in 1999 and 3 in 2000

POTENTIAL BIRD REPELLENTS TO REDUCE BIRD DAMAGE TO LETTUCE SEED AND SEEDLINGS

The authors evaluated the effectiveness of ReJeX-iT® AG-145, Mesurol®, activated charcoal, lime, and fipronil to reduce homed lark damage to lettuce seeds and seedlings. In Experiment 1, homed larks consumed significantly more feed mixture (50:50 grains and lettuce seed) than untreated clay-coated lettuce seed in a three-day choice-test. In Experiment 2, where clay-coated lettuce seed was treated with ReJeX-iT® AG- 145, Mesurol®, activated charcoal, or lime, there was no significant difference in consumption of untreated clay-coated lettuce seed and treated clay-coated lettuce seed. Homed larks consumed insignificant amounts of all seed treatments including untreated coated lettuce seed. In this experiment homed larks lost an average of 28 % of their body weight over the three-day test period. It was concluded that the clay seed coating alone reduced damage significantly. In the aviary test, flats of sprouting lettuce seedlings were sprayed with Mesurol® (4 kg/ha), ReJeX-iT® AG-145 (64 kg/ha), lime (32 kg/ha), activated charcoal (32 kg/ha), and fipronil(4 kg/ha). Mesurol®, ReJeX-iT® AG-145, and lime significantly reduced consumption of lettuce seedlings over a four-day test period. Even though lime significantly reduced consumption, homed larks still consumed over 50% of the available lettuce seedlings. Field evaluations are warranted with Mesurol® and ReJeX-iT® AG-145

Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries

BACKGROUND: The travel distance from home to a treatment centre, which may impact the stage at diagnosis, has not been investigated for retinoblastoma, the most common childhood eye cancer. We aimed to investigate the travel burden and its impact on clinical presentation in a large sample of patients with retinoblastoma from Africa and Europe. METHODS: A cross-sectional analysis including 518 treatment-naïve patients with retinoblastoma residing in 40 European countries and 1024 treatment-naïve patients with retinoblastoma residing in 43 African countries. RESULTS: Capture rate was 42.2% of expected patients from Africa and 108.8% from Europe. African patients were older (95% CI -12.4 to -5.4, p<0.001), had fewer cases of familial retinoblastoma (95% CI 2.0 to 5.3, p<0.001) and presented with more advanced disease (95% CI 6.0 to 9.8, p<0.001); 43.4% and 15.4% of Africans had extraocular retinoblastoma and distant metastasis at the time of diagnosis, respectively, compared to 2.9% and 1.0% of the Europeans. To reach a retinoblastoma centre, European patients travelled 421.8 km compared to Africans who travelled 185.7 km (p<0.001). On regression analysis, lower-national income level, African residence and older age (p<0.001), but not travel distance (p=0.19), were risk factors for advanced disease. CONCLUSIONS: Fewer than half the expected number of patients with retinoblastoma presented to African referral centres in 2017, suggesting poor awareness or other barriers to access. Despite the relatively shorter distance travelled by African patients, they presented with later-stage disease. Health education about retinoblastoma is needed for carers and health workers in Africa in order to increase capture rate and promote early referral

Global Retinoblastoma Presentation and Analysis by National Income Level

Importance: Early diagnosis of retinoblastoma, the most common intraocular cancer, can save both a child's life and vision. However, anecdotal evidence suggests that many children across the world are diagnosed late. To our knowledge, the clinical presentation of retinoblastoma has never been assessed on a global scale. Objectives: To report the retinoblastoma stage at diagnosis in patients across the world during a single year, to investigate associations between clinical variables and national income level, and to investigate risk factors for advanced disease at diagnosis. Design, Setting, and Participants: A total of 278 retinoblastoma treatment centers were recruited from June 2017 through December 2018 to participate in a cross-sectional analysis of treatment-naive patients with retinoblastoma who were diagnosed in 2017. Main Outcomes and Measures: Age at presentation, proportion of familial history of retinoblastoma, and tumor stage and metastasis. Results: The cohort included 4351 new patients from 153 countries; the median age at diagnosis was 30.5 (interquartile range, 18.3-45.9) months, and 1976 patients (45.4%) were female. Most patients (n = 3685 [84.7%]) were from low- A nd middle-income countries (LMICs). Globally, the most common indication for referral was leukocoria (n = 2638 [62.8%]), followed by strabismus (n = 429 [10.2%]) and proptosis (n = 309 [7.4%]). Patients from high-income countries (HICs) were diagnosed at a median age of 14.1 months, with 656 of 666 (98.5%) patients having intraocular retinoblastoma and 2 (0.3%) having metastasis. Patients from low-income countries were diagnosed at a median age of 30.5 months, with 256 of 521 (49.1%) having extraocular retinoblastoma and 94 of 498 (18.9%) having metastasis. Lower national income level was associated with older presentation age, higher proportion of locally advanced disease and distant metastasis, and smaller proportion of familial history of retinoblastoma. Advanced disease at diagnosis was more common in LMICs even after adjusting for age (odds ratio for low-income countries vs upper-middle-income countries and HICs, 17.92 [95% CI, 12.94-24.80], and for lower-middle-income countries vs upper-middle-income countries and HICs, 5.74 [95% CI, 4.30-7.68]). Conclusions and Relevance: This study is estimated to have included more than half of all new retinoblastoma cases worldwide in 2017. Children from LMICs, where the main global retinoblastoma burden lies, presented at an older age with more advanced disease and demonstrated a smaller proportion of familial history of retinoblastoma, likely because many do not reach a childbearing age. Given that retinoblastoma is curable, these data are concerning and mandate intervention at national and international levels. Further studies are needed to investigate factors, other than age at presentation, that may be associated with advanced disease in LMICs

Global Retinoblastoma Presentation and Analysis by National Income Level.

Importance: Early diagnosis of retinoblastoma, the most common intraocular cancer, can save both a child's life and vision. However, anecdotal evidence suggests that many children across the world are diagnosed late. To our knowledge, the clinical presentation of retinoblastoma has never been assessed on a global scale. Objectives: To report the retinoblastoma stage at diagnosis in patients across the world during a single year, to investigate associations between clinical variables and national income level, and to investigate risk factors for advanced disease at diagnosis. Design, Setting, and Participants: A total of 278 retinoblastoma treatment centers were recruited from June 2017 through December 2018 to participate in a cross-sectional analysis of treatment-naive patients with retinoblastoma who were diagnosed in 2017. Main Outcomes and Measures: Age at presentation, proportion of familial history of retinoblastoma, and tumor stage and metastasis. Results: The cohort included 4351 new patients from 153 countries; the median age at diagnosis was 30.5 (interquartile range, 18.3-45.9) months, and 1976 patients (45.4%) were female. Most patients (n = 3685 [84.7%]) were from low- and middle-income countries (LMICs). Globally, the most common indication for referral was leukocoria (n = 2638 [62.8%]), followed by strabismus (n = 429 [10.2%]) and proptosis (n = 309 [7.4%]). Patients from high-income countries (HICs) were diagnosed at a median age of 14.1 months, with 656 of 666 (98.5%) patients having intraocular retinoblastoma and 2 (0.3%) having metastasis. Patients from low-income countries were diagnosed at a median age of 30.5 months, with 256 of 521 (49.1%) having extraocular retinoblastoma and 94 of 498 (18.9%) having metastasis. Lower national income level was associated with older presentation age, higher proportion of locally advanced disease and distant metastasis, and smaller proportion of familial history of retinoblastoma. Advanced disease at diagnosis was more common in LMICs even after adjusting for age (odds ratio for low-income countries vs upper-middle-income countries and HICs, 17.92 [95% CI, 12.94-24.80], and for lower-middle-income countries vs upper-middle-income countries and HICs, 5.74 [95% CI, 4.30-7.68]). Conclusions and Relevance: This study is estimated to have included more than half of all new retinoblastoma cases worldwide in 2017. Children from LMICs, where the main global retinoblastoma burden lies, presented at an older age with more advanced disease and demonstrated a smaller proportion of familial history of retinoblastoma, likely because many do not reach a childbearing age. Given that retinoblastoma is curable, these data are concerning and mandate intervention at national and international levels. Further studies are needed to investigate factors, other than age at presentation, that may be associated with advanced disease in LMICs

Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries

BACKGROUND: The travel distance from home to a treatment centre, which may impact the stage at diagnosis, has not been investigated for retinoblastoma, the most common childhood eye cancer. We aimed to investigate the travel burden and its impact on clinical presentation in a large sample of patients with retinoblastoma from Africa and Europe. METHODS: A cross-sectional analysis including 518 treatment-naïve patients with retinoblastoma residing in 40 European countries and 1024 treatment-naïve patients with retinoblastoma residing in 43 African countries. RESULTS: Capture rate was 42.2% of expected patients from Africa and 108.8% from Europe. African patients were older (95% CI -12.4 to -5.4, p<0.001), had fewer cases of familial retinoblastoma (95% CI 2.0 to 5.3, p<0.001) and presented with more advanced disease (95% CI 6.0 to 9.8, p<0.001); 43.4% and 15.4% of Africans had extraocular retinoblastoma and distant metastasis at the time of diagnosis, respectively, compared to 2.9% and 1.0% of the Europeans. To reach a retinoblastoma centre, European patients travelled 421.8 km compared to Africans who travelled 185.7 km (p<0.001). On regression analysis, lower-national income level, African residence and older age (p<0.001), but not travel distance (p=0.19), were risk factors for advanced disease. CONCLUSIONS: Fewer than half the expected number of patients with retinoblastoma presented to African referral centres in 2017, suggesting poor awareness or other barriers to access. Despite the relatively shorter distance travelled by African patients, they presented with later-stage disease. Health education about retinoblastoma is needed for carers and health workers in Africa in order to increase capture rate and promote early referral

The global retinoblastoma outcome study : a prospective, cluster-based analysis of 4064 patients from 149 countries

DATA SHARING : The study data will become available online once all analyses are complete.BACKGROUND : Retinoblastoma is the most common intraocular cancer worldwide. There is some evidence to suggest that major differences exist in treatment outcomes for children with retinoblastoma from different regions, but these differences have not been assessed on a global scale. We aimed to report 3-year outcomes for children with retinoblastoma globally and to investigate factors associated with survival. METHODS : We did a prospective cluster-based analysis of treatment-naive patients with retinoblastoma who were diagnosed between Jan 1, 2017, and Dec 31, 2017, then treated and followed up for 3 years. Patients were recruited from 260 specialised treatment centres worldwide. Data were obtained from participating centres on primary and additional treatments, duration of follow-up, metastasis, eye globe salvage, and survival outcome. We analysed time to death and time to enucleation with Cox regression models. FINDINGS : The cohort included 4064 children from 149 countries. The median age at diagnosis was 23·2 months (IQR 11·0–36·5). Extraocular tumour spread (cT4 of the cTNMH classification) at diagnosis was reported in five (0·8%) of 636 children from high-income countries, 55 (5·4%) of 1027 children from upper-middle-income countries, 342 (19·7%) of 1738 children from lower-middle-income countries, and 196 (42·9%) of 457 children from low-income countries. Enucleation surgery was available for all children and intravenous chemotherapy was available for 4014 (98·8%) of 4064 children. The 3-year survival rate was 99·5% (95% CI 98·8–100·0) for children from high-income countries, 91·2% (89·5–93·0) for children from upper-middle-income countries, 80·3% (78·3–82·3) for children from lower-middle-income countries, and 57·3% (52·1-63·0) for children from low-income countries. On analysis, independent factors for worse survival were residence in low-income countries compared to high-income countries (hazard ratio 16·67; 95% CI 4·76–50·00), cT4 advanced tumour compared to cT1 (8·98; 4·44–18·18), and older age at diagnosis in children up to 3 years (1·38 per year; 1·23–1·56). For children aged 3–7 years, the mortality risk decreased slightly (p=0·0104 for the change in slope). INTERPRETATION : This study, estimated to include approximately half of all new retinoblastoma cases worldwide in 2017, shows profound inequity in survival of children depending on the national income level of their country of residence. In high-income countries, death from retinoblastoma is rare, whereas in low-income countries estimated 3-year survival is just over 50%. Although essential treatments are available in nearly all countries, early diagnosis and treatment in low-income countries are key to improving survival outcomes.The Queen Elizabeth Diamond Jubilee Trust and the Wellcome Trust.https://www.thelancet.com/journals/langlo/homeam2023Paediatrics and Child Healt